RUNX1-Driven CPXM1 Transcription Promotes Malignant Phenotypes and EMT in Gastric Cancer Cells [0.03%]
RUNX1驱动的CPXM1转录促进胃癌细胞恶性表型和上皮间质转化
Ping Jia,Fengming Xu,Tao Zhou et al.
Ping Jia et al.
Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, with current treatment strategies largely limited to surgery, chemotherapy, and targeted therapy. Although the glycoprotein CPXM1 has been implicated in tumo...
Adipocyte-Derived Palmitic Acid Promotes Breast Cancer Malignancy via ZDHHC15-Mediated S-Palmitoylation of PPARγ [0.03%]
脂肪细胞源性棕榈酸通过ZDHHC15介导的PPARγS-棕榈酰化促进乳腺癌恶性进展
Geon Ho Moon,Min Young Lee,Jiwon Koh et al.
Geon Ho Moon et al.
Peroxisome proliferator-activated receptor gamma (PPARγ), a well-characterized regulator of adipogenesis, also functions as a tumor suppressor in breast cancer. However, the PPARγ agonist rosiglitazone has shown limited clinical efficacy,...
Nicotinic Acid Restriction Enhances the Therapeutic Benefit of NAMPT Inhibition in Small-Cell Lung Cancer Models [0.03%]
烟酸限制可增强NAMPT抑制在小细胞肺癌模型中的治疗作用
Kyoji Tsurumi,Miyuki Nomura,Mai Ouchi et al.
Kyoji Tsurumi et al.
Small-cell lung cancer (SCLC) is an aggressive malignancy with limited therapeutic options. We previously showed that nicotinic acid riboside (NAR) sustains NAD biosynthesis in vivo and compensates for NAMPT inhibition in SCLC models. Here,...
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients [0.03%]
POLASTAR研究中期分析:Pola-R-CHP一线治疗DLBCL患者的疗效和安全性(500例患者)
Takahiro Kumode,Hitomi Sawa,Kohta Miyawaki et al.
Takahiro Kumode et al.
POLASTAR (jRCT1071220082) is a multicenter, prospective observational study evaluating the real-world efficacy and safety of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone (Pola-R-CHP) in Japanese patien...
Targeting the NR3C1-ACSL4 Axis Triggers Ferroptosis to Overcome Radioresistance in Prostate Cancer [0.03%]
靶向NR3C1-ACSL4轴触发铁死亡可克服前列腺癌的放射抵抗性
Jing Yang,Puyuan Chen,Yawen Zheng et al.
Jing Yang et al.
Radioresistance in prostate cancer demands innovative sensitization strategies. We identified the glucocorticoid receptor nuclear receptor subfamily 3 group C member 1 (NR3C1) as a key negative regulator of radiosensitivity linked to poor p...
New Treatment Strategy and Future Research Direction for BRAF-Mutated Cancer [0.03%]
BRAF突变肿瘤的新治疗策略和未来研究方向
Masanobu Takahashi,Sakura Hiraide Taniguchi,Yuya Yoshida
Masanobu Takahashi
BRAF is a key oncogene in various malignancies including malignant melanoma, thyroid cancer, colorectal cancer, and lung cancer. The protein it encodes is a constituent of the mitogen-activated protein kinase pathway that regulates cell gro...
Downregulation of KRTAP2-3 Suppresses Proliferation and Tumor Formation of Oral Cancer Cells via Inactivation of KRAS Signals [0.03%]
角蛋白相关蛋白KRTAP2-3下调通过抑制KRAS信号通路抑制口腔癌细胞的增殖和成瘤能力
Qianqian Miao,Zhijun Huang,Kazuki Takahashi et al.
Qianqian Miao et al.
The progression and metastasis of oral squamous cell carcinoma (OSCC), the most common type of head and neck squamous cell carcinoma (HNSCC), are driven by complex molecular mechanisms, including proliferative signaling pathways such as KRA...
MEN1 Deficiency Drives Lung Cancer Progression via Activation of MMP10-Mediated Angiogenesis [0.03%]
MEN1通过激活MMP10介导的血管生成促进肺癌进展
Chengyu Wei,Xiangyu Liu,Shimin Hu et al.
Chengyu Wei et al.
Angiogenesis is essential for tumor progression, MEN1 gene encodes the menin protein, which is known as a tumor suppressor in lung tissue. Our previous study have shown that vascular density is significantly increased in menin-deficient lun...
Epidemiological and Prognostic Differences in Malignant Mesothelioma Between Eastern China and SEER Database [0.03%]
中国东部与SEER数据库中恶性间皮瘤的流行病学及预后差异
Ningning Li,Ruting Wang,Wenya Zhang et al.
Ningning Li et al.
Eastern China malignant mesothelioma (MM) presents distinct features-younger age, female predominance, and moremalignant peritoneal mesothelioma (MPeM)-contrasting with the Western profile of older males with malignant pleural mesothelioma ...
SERPINE1 Alternative Polyadenylation Influences Gastric Cancer Prognosis via N6-Methyladenosine Modification [0.03%]
胃癌中SERPINE1可变多聚腺苷酸化通过N6-甲基腺苷修饰影响预后
Zhuoyi Wu,Ruyun Xu,Ju Fang et al.
Zhuoyi Wu et al.
Alternative polyadenylation (APA) and N6-methyladenosine (m6A) methylation are critical post-transcriptional regulators in cancer, yet their synergistic role in gastric cancer (GC) remains poorly understood. By integrating RNA-seq and MeRIP...